La Jolla Pharmaceutical (LJPC) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts LJPC Hot Sheet
Join SI Premium – FREE
La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q3 EPS of ($0.70), $0.01 better than the analyst estimate of ($0.71).
For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
